Skip to content
Open access · CC-BY via OpenAlex

Mesenchymal Stem Cells‐Involved Strategies for Rheumatoid Arthritis Therapy

Chaoyang Li, Yifu Sun, Weiguo Xu, Fei Chang, Yinan Wang, Jianxun Ding

Advanced Science · 2024 · ▲ 56 citations

Abstract

Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation of the joints and bone destruction. Because of systemic administration and poor targeting, traditional anti-rheumatic drugs have unsatisfactory treatment efficacy and strong side effects, including myelosuppression, liver or kidney function damage, and malignant tumors. Consequently, mesenchymal stem cells (MSCs)-involved therapy is proposed for RA therapy as a benefit of their immunosuppressive and tissue-repairing effects. This review summarizes the progress of MSCs-involved RA therapy through suppressing inflammation and promoting tissue regeneration and predicts their potential clinical application.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1002/advs.202305116
Canonical
link ↗
Fetched
2026-11-07 MST

Cite this

APA
Li, C., Sun, Y., Xu, W., Chang, F., Wang, Y., &amp; Ding, J. (2024). Mesenchymal Stem Cells‐Involved Strategies for Rheumatoid Arthritis Therapy. <em>Advanced Science</em>. https://doi.org/10.1002/advs.202305116
Vancouver
Li C, Sun Y, Xu W, Chang F, Wang Y, Ding J. Mesenchymal Stem Cells‐Involved Strategies for Rheumatoid Arthritis Therapy. Advanced Science. 2024. doi:10.1002/advs.202305116.
BibTeX
@article{chaoyang2024Mesenc, title = {Mesenchymal Stem Cells‐Involved Strategies for Rheumatoid Arthritis Therapy}, author = {Chaoyang Li and Yifu Sun and Weiguo Xu and Fei Chang and Yinan Wang and Jianxun Ding}, journal = {Advanced Science}, year = {2024}, doi = {10.1002/advs.202305116}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings